AI-generated · cited to primary sources · not investment advice
Dr Agarwal's Hea (544350) Mar 2025 Filing Analysis
What could break the thesis?
Geographic concentration remains high but is gradually diversifying. Revenue from the South region decreased from 64% to 63.1% of the payor mix, and the company is aggressively expanding into the North (Delhi NCR, Punjab) and West (Gujarat).
“Approximately 65% of our Indian network is present in cities beyond the top metropolitan areas”
Execution risk remains high as the company added 59 new facilities in FY25. The EBITDA margin saw a slight decline from 29.5% in FY24 to 28.6% in FY25 due to the ramp-up of these new centers.
“We added 59 new facilities this year”
The international revenue contribution remains stable at 10.1% of total revenue. The company operates 18 facilities across nine African countries, maintaining a consistent footprint.
“We commenced operations in Africa in 2012 and have since expanded to 18 facilities across nine”
See the full cited Risk analysis of Dr Agarwal's Hea
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.